Sneak Peek: Nine Evolutions in Clinical Research & Patient Recruitment

Sneak Peek Nine Evolutions in Clinical Research & Patient Recruitment

Sneak Peek: Nine Evolutions in Clinical Research & Patient Recruitment

Any good scientist should know that in order to keep up, you must constantly evolve your techniques. That’s especially true in the realm of clinical development, where balancing the challenges of patient-centric clinical trials with increasingly tighter budgets and shorter timelines is paramount to success.

UBC’s experts are here to help. In our free whitepaper, “Nine Evolutions in Clinical Research & Patient Recruitment: A 2016 Preview,” we share an in-depth look at the trends driving clinical trial participation. Here’s a look at one of the revolutions we cover in the whitepaper:

“Participants: From Patients to Volunteers

Many protocols are written to address existing or even retrospective evidence of medical need, which means that clinical trial participation is primarily focused on individuals with a recent, diagnosed health concern. However, as we look to the future, communication about and access to clinical trials will develop such that participation is a role that all people, regardless of health status, can fill. For example, there are presently registries and databases for the healthy off-spring of patients with Alzheimer’s disease that can be followed longitudinally for the potential of early intervention due to the possibility of developing the disease based on genetic risk factors. This also holds for currently healthy family members of patients with rare diseases and cancers, who may also have high-risk factors.

With this development, new opportunities exist to gather data from subjects who don’t fall into the typical methods of recruitment and research participation:

  • Apple’s ResearchKit™ is just one tool allowing clinical research to reach the mainstream. Within a day of the March 2015 launch of ResearchKit™, thousands of volunteers signed up to participate in studies. The ResearchKit™ allows manufacturers and other researchers a means to take their studies out of a clinical setting and directly into participants’ hands. What may have taken a year in patient recruitment efforts could now take a matter of days.
     
  • In his January 2015 State of the Union address, President Barack Obama announced the DNA Sequencing Project and called for federal funding for a national research program tracking the data of one million volunteer donors, including their DNA sequences.

Manufacturers will want to consider how to reach volunteer participants and the best study designs to optimize the vast amounts of genomic data they can provide.

 

This is a must read for pharmaceutical and biotech sponsors launching or conducting trials in 2016 and beyond.